Renovaro Inc (RENB)

$0.23 -0.02 (-6.37%)
Market Cap 42.58M
Revenue (ttm) 0.00
Net Income (ttm) -80.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,050,407
Avg Vol 4,026,646
Day's Range N/A - N/A
Shares Out 172.12M
Stochastic %K 6%
Beta 0.54
Analysts Strong Buy
Price Target N/A

Company Profile

Renovaro Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands. It operates through two segments, RENB and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an art...

Industry: Biotechnology
Sector: Healthcare
Phone: 305 918 1980
Address:
2080 Century Park East, Suite 906, Los Angeles, United States
Stengaard1
Stengaard1 Aug. 7 at 6:38 PM
$RENB The private sector is already on the case. Companies like Renovaro, and OpenAI, two U.S.-based AI firms, are already applying machine learning to both prevent AI from producing recipes for weaponry and to identify and counter biological and chemical threats before they can spiral out of control... unquote... Nice company to be mentioned in....
0 · Reply
MarketForecasting
MarketForecasting Aug. 7 at 6:26 PM
$RENB Reverse split at .10 cents will be disastrous . 🪦 RIP SHAREHOLDERS
0 · Reply
paok44
paok44 Aug. 7 at 5:43 PM
$RENB Με τα αρθρα στη παλαμη θα μεινουμε στο τελος!!
0 · Reply
Stengaard1
Stengaard1 Aug. 7 at 4:31 PM
$RENB A very interesting article dy Dr. David Gangemi, PhD a renowned virologist working for the U.S.Army - In he article he mentions 2 (two) companies who are targeting this threat - Open AI and Renovaro.... https://www.realcleardefense.com/articles/2025/08/07/ai_can_be_used_to_develop_biological_and_chemical_weapons_1127450.html
1 · Reply
11thestate
11thestate Aug. 7 at 4:51 AM
Took a hit on $ENOB / $RENB? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/enochian-biosciences-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08072025_1 #ENOB
0 · Reply
paok44
paok44 Aug. 6 at 9:07 PM
$RENB ερχεται διαγραφη, επιτελους!!! https://www.tipranks.com/news/company-announcements/renovaro-biosciences-granted-nasdaq-compliance-extension?mod=mw_quote_news
0 · Reply
Yassin_tet
Yassin_tet Aug. 6 at 3:32 PM
$RENB all the damned pennystocks...all active in the stock market to steal...why not the rules make them want to steal more
1 · Reply
MarketForecasting
MarketForecasting Aug. 6 at 3:27 PM
$RENB shutting down operations soon
0 · Reply
BALLER808
BALLER808 Aug. 5 at 7:57 PM
$RENB with ups and down in the past there will be more i guess, im in for it baby
2 · Reply
RobertVanhuss215
RobertVanhuss215 Aug. 5 at 3:13 PM
$RENB is working in real estate, while AITX is protecting those assets through cutting-edge security robots. 4× revs leaves room for upside.
0 · Reply
Latest News on RENB
Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Jul 28, 2025, 10:38 AM EDT - 10 days ago

Renovaro Secures Key AI Patents, Strengthening Market Position in $20B Biomedical AI Sector

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Jul 17, 2025, 9:15 AM EDT - 21 days ago

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Jul 9, 2025, 8:00 AM EDT - 4 weeks ago

Renovaro Strengthens Balance Sheet Through Debt Conversion and Advances AI-Driven Initiatives

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Jun 30, 2025, 9:21 AM EDT - 5 weeks ago

Renovaro Launches AI-Based Neurotoxin Countermeasure Initiative Addressing Emerging National Security Needs

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

Jun 3, 2025, 9:15 AM EDT - 2 months ago

Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 22, 2025, 3:12 PM EDT - 2 months ago

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

May 22, 2025, 11:05 AM EDT - 2 months ago

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

May 14, 2025, 9:15 AM EDT - 3 months ago

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

May 13, 2025, 9:15 AM EDT - 3 months ago

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Apr 22, 2025, 9:20 AM EDT - 3 months ago

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Apr 9, 2025, 9:25 AM EDT - 4 months ago

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Apr 4, 2025, 9:40 AM EDT - 4 months ago

Renovaro Provides Update to Definitive Agreement with Predictive Oncology

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Mar 3, 2025, 9:15 AM EST - 5 months ago

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Feb 26, 2025, 1:25 PM EST - 5 months ago

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Renovaro Announces $15 million in Equity Committed

Feb 26, 2025, 9:15 AM EST - 5 months ago

Renovaro Announces $15 million in Equity Committed

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

Jan 7, 2025, 6:51 PM EST - 7 months ago

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

POAI

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Jan 7, 2025, 9:15 AM EST - 7 months ago

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

Renovaro Issues Shareholder Letter and Provides Corporate Update

Jan 7, 2025, 9:15 AM EST - 7 months ago

Renovaro Issues Shareholder Letter and Provides Corporate Update

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Jan 6, 2025, 9:15 AM EST - 7 months ago

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

Dec 30, 2024, 9:00 AM EST - 7 months ago

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Dec 23, 2024, 9:00 AM EST - 8 months ago

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

Renovaro Regains Compliance with NASDAQ Listing Requirement

Dec 20, 2024, 3:40 PM EST - 8 months ago

Renovaro Regains Compliance with NASDAQ Listing Requirement

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

Dec 20, 2024, 9:00 AM EST - 8 months ago

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

Oct 17, 2024, 9:15 AM EDT - 10 months ago

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

Renovaro Announces Strategic Restructuring and Leadership Transition

Oct 16, 2024, 9:28 AM EDT - 10 months ago

Renovaro Announces Strategic Restructuring and Leadership Transition

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

Sep 13, 2024, 9:00 AM EDT - 11 months ago

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

Sep 11, 2024, 9:15 AM EDT - 11 months ago

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

Renovaro, Inc. Announces $10 million in Equity Committed

Jun 14, 2024, 9:06 AM EDT - 1 year ago

Renovaro, Inc. Announces $10 million in Equity Committed

Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

May 24, 2024, 9:20 AM EDT - 1 year ago

Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB)

May 21, 2024, 8:39 AM EDT - 1 year ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB)

BAX RAPT SAGE TMCI

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

Apr 30, 2024, 11:00 AM EDT - 1 year ago

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

Apr 24, 2024, 9:00 AM EDT - 1 year ago

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient C

Apr 18, 2024, 8:45 AM EDT - 1 year ago

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient C

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

Feb 15, 2024, 9:25 AM EST - 1 year ago

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

Statement of Renovaro Inc

Feb 14, 2024, 10:01 AM EST - 1 year ago

Statement of Renovaro Inc

AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

Feb 13, 2024, 9:31 AM EST - 1 year ago

AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine

Renovaro Biosciences Announces Results of Special Meeting of Shareholders

Jan 25, 2024, 12:45 PM EST - 1 year ago

Renovaro Biosciences Announces Results of Special Meeting of Shareholders

Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD

Jan 16, 2024, 8:00 AM EST - 1 year ago

Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD

RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB

Jan 10, 2024, 5:21 PM EST - 1 year ago

RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB

Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors

Oct 11, 2023, 9:25 AM EDT - 1 year ago

Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors

Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors

Oct 10, 2023, 8:00 AM EDT - 1 year ago

Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors

Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD

Oct 2, 2023, 12:05 PM EDT - 2 years ago

Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD

AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine

Oct 2, 2023, 9:25 AM EDT - 2 years ago

AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine

Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine

Sep 29, 2023, 9:15 AM EDT - 2 years ago

Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine

GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine

Sep 29, 2023, 9:15 AM EDT - 2 years ago

GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine

Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort

Aug 30, 2023, 9:15 AM EDT - 2 years ago

Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort

Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer

Aug 21, 2023, 9:15 AM EDT - 2 years ago

Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer

AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer

Aug 9, 2023, 9:00 AM EDT - 2 years ago

AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer

Stengaard1
Stengaard1 Aug. 7 at 6:38 PM
$RENB The private sector is already on the case. Companies like Renovaro, and OpenAI, two U.S.-based AI firms, are already applying machine learning to both prevent AI from producing recipes for weaponry and to identify and counter biological and chemical threats before they can spiral out of control... unquote... Nice company to be mentioned in....
0 · Reply
MarketForecasting
MarketForecasting Aug. 7 at 6:26 PM
$RENB Reverse split at .10 cents will be disastrous . 🪦 RIP SHAREHOLDERS
0 · Reply
paok44
paok44 Aug. 7 at 5:43 PM
$RENB Με τα αρθρα στη παλαμη θα μεινουμε στο τελος!!
0 · Reply
Stengaard1
Stengaard1 Aug. 7 at 4:31 PM
$RENB A very interesting article dy Dr. David Gangemi, PhD a renowned virologist working for the U.S.Army - In he article he mentions 2 (two) companies who are targeting this threat - Open AI and Renovaro.... https://www.realcleardefense.com/articles/2025/08/07/ai_can_be_used_to_develop_biological_and_chemical_weapons_1127450.html
1 · Reply
11thestate
11thestate Aug. 7 at 4:51 AM
Took a hit on $ENOB / $RENB? You’re not alone — and there’s a way forward. Find out how to recover: https://11th.com/cases/enochian-biosciences-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=stlm&utm_content=08072025_1 #ENOB
0 · Reply
paok44
paok44 Aug. 6 at 9:07 PM
$RENB ερχεται διαγραφη, επιτελους!!! https://www.tipranks.com/news/company-announcements/renovaro-biosciences-granted-nasdaq-compliance-extension?mod=mw_quote_news
0 · Reply
Yassin_tet
Yassin_tet Aug. 6 at 3:32 PM
$RENB all the damned pennystocks...all active in the stock market to steal...why not the rules make them want to steal more
1 · Reply
MarketForecasting
MarketForecasting Aug. 6 at 3:27 PM
$RENB shutting down operations soon
0 · Reply
BALLER808
BALLER808 Aug. 5 at 7:57 PM
$RENB with ups and down in the past there will be more i guess, im in for it baby
2 · Reply
RobertVanhuss215
RobertVanhuss215 Aug. 5 at 3:13 PM
$RENB is working in real estate, while AITX is protecting those assets through cutting-edge security robots. 4× revs leaves room for upside.
0 · Reply
paok44
paok44 Aug. 5 at 1:11 PM
$RENB Ενα μπουρδελο ειναι η εταιρεια!!! ποτε θα την διαγραψουν να ησυχασουμε??
0 · Reply
MarketForecasting
MarketForecasting Aug. 4 at 5:19 PM
$RENB they can’t split fast enough , this company is a joke , a criminal entity .
1 · Reply
Aristoteli
Aristoteli Aug. 4 at 9:10 AM
$RENB voted already No
0 · Reply
Yassin_tet
Yassin_tet Aug. 2 at 9:18 AM
$RENB f..offf thats from weeks back
1 · Reply
ConstanceAtkeson887
ConstanceAtkeson887 Aug. 1 at 4:18 PM
$RENB shows promise in climate and tech, but AITX already has operational product lines and client retention — and it’s valued at just 4× revenue.
0 · Reply
Sewdot
Sewdot Aug. 1 at 3:39 PM
$RENB $AMZN $GOOGL $GOOG Not from today, I just like this to be placed at the top of the RENB board. That said, I'm bearish (I'm not...I just want cheaper shaaaaaares )
0 · Reply
Yassin_tet
Yassin_tet Aug. 1 at 12:29 PM
$RENB where is stengaard
0 · Reply
Market_Magician
Market_Magician Jul. 31 at 6:26 PM
$RENB trying to buy 75,000 shares here
1 · Reply
TruffleShuffle47
TruffleShuffle47 Jul. 31 at 6:22 PM
$RENB
0 · Reply
paok44
paok44 Jul. 31 at 12:22 PM
$RENB They're even unloading it in the pre-sale, they'll tear it up by 8/15
1 · Reply
MarketForecasting
MarketForecasting Jul. 30 at 4:42 PM
$RENB Paid Spam Advertising
0 · Reply
MoneySwell
MoneySwell Jul. 30 at 3:10 PM
$AVAI $GEHC $HCTI $MDAI $RENB MAIGA! Making AI Great Again Again! AI Just Got a Green Light from the White House 🚀🇺🇸 https://markets.ft.com/data/announce/detail?dockey=600-202507291501PR_NEWS_USPRX____LN40065-1
0 · Reply